In a bid to defuse sharp criticism of prescription drug pricing, the nation’s largest pharmacy benefit manager, Express Scripts, and several pharmaceutical companies are teaming up to offer discounts on more than three dozen brand medicines.

The program, called InsideRx, is geared primarily to patients who lack insurance or who have high-deductible health plans, and offers average discounts of 34 percent on medicines for treating diabetes, high cholesterol, acid reflux, and respiratory problems such as asthma.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I have to see it to believe it. Lowering prices many can talk about but walking the talk is a challenge and it is hard. Another question is can they be sustained?

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy